TP53 and colorectal carcinoma: Although additional studies will be warranted to elucidate the molecular mechanisms that are associated with P72wt or mutant phenotypes of p53, our results suggest that the P72 polymorphism of p53 in CRC is a gain of function alteration leading to activation of tumor promoting phenotype.